Interplay between the skin barrier and immune cells in patients with atopic dermatitis unraveled by means of mathematical modeling  David Bending, PhD,

Slides:



Advertisements
Similar presentations
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Advertisements

D-dimer: A biomarker for antihistamine-resistant chronic urticaria
“Inflammatory skin march”: IL-1–mediated skin inflammation, atopic dermatitis, and psoriasis to cardiovascular events  Keiichi Yamanaka, MD, PhD, Hitoshi.
Doina M. Racila, MD, Joel N. Kline, MD, MSc 
Clarification concerning amoxicillin skin testing
Natalija Novak, MD  Journal of Allergy and Clinical Immunology 
Mechanisms of nutrient modulation of the immune response
Advances in food allergy in 2015
Donald Y.M. Leung, MD, PhD, Emma Guttman-Yassky, MD, PhD 
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Atopic dermatitis: Age and race do matter!
Therapeutic pipeline for atopic dermatitis: End of the drought?
Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents
Allergic skin diseases
An Infant with Atopic Dermatitis and Itching After Ingestion of Milk
Rising prevalence of asthma is sex-specific in a US farming population
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Potential mechanisms for the hypothesized link between sunshine, vitamin D, and food allergy in children  Milo F. Vassallo, MD, PhD, Carlos A. Camargo,
Evaluation of Food Allergy in Patients with Atopic Dermatitis
Physician needs in health informatics: Just ask the docs
Mathematical modeling of atopic dermatitis reveals “double-switch” mechanisms underlying 4 common disease phenotypes  Elisa Domínguez-Hüttinger, PhD,
Peter M. Wolfgram, MD, David B. Allen, MD 
The future of allergy/immunology: Promising young investigators
Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march  Tali.
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Reply Journal of Allergy and Clinical Immunology
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
What are the best outcome measurements for atopic eczema
Atopic dermatitis: A practice parameter update 2012
Phillip Lieberman, MD, David Golden, MD 
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A
Invasive fungal disease in autosomal-dominant hyper-IgE syndrome
Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think  Martin L. Moore, PhD, R.
What is an “eosinophilic phenotype” of asthma?
Liam O’Mahony, PhD, Mübeccel Akdis, MD, PhD, Cezmi A. Akdis, MD 
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Autophagy: Nobel Prize 2016 and allergy and asthma research
IL-2– and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets  Sven Létourneau, DPhil, Carsten Krieg, PhD, Giuseppe Pantaleo,
News & Notes Journal of Allergy and Clinical Immunology
Staphylococcus aureus density on lesional and nonlesional skin is strongly associated with disease severity in atopic dermatitis  Marie Tauber, MD, Stefana.
Aaron M. Drucker, MD, Paula J. Harvey, PhD 
The Editors' Choice Journal of Allergy and Clinical Immunology
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
New pathways for itching in patients with atopic dermatitis?
News Beyond Our Pages Journal of Allergy and Clinical Immunology
The Editors' Choice Journal of Allergy and Clinical Immunology
Benjamin Chaigne, MD, Hervé Watier, MD, PhD 
Reply Journal of Allergy and Clinical Immunology
Does “autoreactivity” play a role in atopic dermatitis?
Advances in basic and clinical immunology in 2013
Measles and immunomodulation
Stefan Schülke, PhD, Stefan Vieths, PhD 
Clinical Management of Atopic Dermatitis: Practical Highlights and Updates from the Atopic Dermatitis Practice Parameter 2012  Peter A. Lio, MD, Margaret.
Macrolide antibiotics and asthma treatment
TH2 adjuvants: Implications for food allergy
Asthma: The past, future, environment, and costs
Interrupting IL-6–receptor signaling improves atopic dermatitis but associates with bacterial superinfection  Alexander A. Navarini, MD, PhD, Lars E.
Environmental factors and eosinophilic esophagitis
Kinase inhibitors in clinical practice: An expanding world
Lisa A. Beck, MD, Sarbjit Saini, MD 
Contrasting pathogenesis of atopic dermatitis and psoriasis—Part II: Immune cell subsets and therapeutic concepts  Emma Guttman-Yassky, MD, PhD, Kristine.
Safety and efficacy of repeated monthly carboplatin desensitization
Natural history of cow’s milk allergy
Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2010  Scott H. Sicherer, MD, Donald Y.M.
Primary prevention of asthma and allergy
Itching as a systemic disease
Presentation transcript:

Interplay between the skin barrier and immune cells in patients with atopic dermatitis unraveled by means of mathematical modeling  David Bending, PhD, Masahiro Ono, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 139, Issue 6, Pages 1790-1792 (June 2017) DOI: 10.1016/j.jaci.2017.03.015 Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Schematic presentation of the double-switch model of AD proposed by Domínguez-Hüttinger et al.5 The authors analyzed the literature and constructed a mathematical model with which they performed in silico experiments and assessed the dynamics of the skin and immune systems over time, testing innumerous conditions by changing model parameters. These investigations led to establishment of the double-switch model. The skin barrier defect allows microbial invasion of the epidermal layers, which activates pattern recognition receptors (PRR; depicted by yellow stars) in keratinocytes. This activation status is reversible (reversible switch). The activation of keratinocytes is conveyed to DCs, which promote the differentiation of naive T cells into TH2 cells. TH2 cell differentiation is considered irreversible in the model (irreversible switch). Differentiated TH2 cells further dysregulate keratinocyte functions. Journal of Allergy and Clinical Immunology 2017 139, 1790-1792DOI: (10.1016/j.jaci.2017.03.015) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions